详细说明
Species Reactivity
Human
Specificity
Detects human DRAK1 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) DRAK2, rhDAPK1, rhDAPK2, or rhDAPK3 is observed. In Western blots, no cross-reactivity with rhDRAK2 is observed.
Source
Monoclonal Mouse IgG 1 Clone # 684324
Purification
Protein A or G purified from hybridoma culture supernatant
Immunogen
E. coli-derived recombinant human DRAK1
Ala115-Glu313
Accession # Q9UEE5Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Label
Unconjugated
Applications
Recommended
ConcentrationSample
Western Blot
1 µg/mL
See below
Please Note: Optimal dilutions should be determined by each laboratory for each application. are available in the Technical Information section on our website.
Data Examples
Western Blot | Detection of Human DRAK1 by Western Blot. Western blot shows lysates of MOLT‑4 human acute lymphoblastic leukemia cell line and A431 human epithelial carcinoma cell line. PVDF Membrane was probed with 1 µg/mL of Mouse Anti-Human DRAK1 Monoclonal Antibody (Catalog # MAB4985) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # ). A specific band was detected for DRAK1 at approximately 55 kDa (as indicated). This experiment was conducted under reducing conditions and using . |
Preparation and Storage
Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: DRAK1
DRAK1 (DAP kinase-related apoptosis-inducing protein kinase 1; also STK17A) is a 55 kDa member of the DAP kinase subfamily, CAMK Ser/Thr protein kinase family of enzymes. It is expressed in osteoclasts, resides in the nucleus, and initiates apoptosis. Human DRAK1 is 414 amino acids (aa) in length. It contains an N-terminal polyPro segment (aa 33-37) followed by a Ser/Thr kinase domain (aa 64-321) with a catalytic loop (aa 184-193). Apoptosis apparently requires an intact kinase domain. No rodent DRAK1 has been reported. Over aa 115-313, human DRAK1 shares 95% aa identity with canine DRAK1, and 65% aa identity with human DRAK2.
Long Name:
DAP Kinase-related Apoptosis-inducing Protein Kinase 1
Entrez Gene IDs:
9263 (Human)
Alternate Names:
DAP kinase-related apoptosis-inducing protein kinase 1; DRAK1; DRAK1death-associated protein kinase-related 1; EC 2.7.11.1; serine/threonine kinase 17a (apoptosis-inducing); serine/threonine kinase 17a; serine/threonine-protein kinase 17A; STK17A